addiction

Description This report examines hospitalisation trends related to cannabis use and mental and behavioural disorders in Canada between 2006 and 2015. During this period, the rate of hospitalizations related to cannabis use and mental and...

This page offers background information and tips for providers to keep in mind while using person-frst language, as well as terms to avoid to reduce stigma and negative bias when discussing addiction.

The National Institute on Drug Abuse has put together information on the potential implications of this pandemic on those who struggle with substance use disorder. The social distancing that is required during this COVID-19 outbreak has put...

This webinar is the first in a series called “Supporting People With Addiction During COVID-19”, hosted by the National Academy of Medicine and the American Society for Addiction Medicine.

Matej Kosir, Director, the Utrip Research and Development Institute (UTRIP) discusses how to successfully advocate for new university programming on drug demand reduction.

The Action Collaborative on Countering the U.S. Opioid Epidemic held a web-based listening session that focused on the perspectives and experiences of clinicians caring for patients with chronic, non-cancer pain. This is a recording of that...

In this presentation, Dr. Valerie Earnshaw provides a cross-cutting conceptual overview of stigma, identifies targets for stigma measurement, recommends methodological approaches for stigma research, and reviews the intervention toolkit to...

Description: Drugs of abuse target discrete collections of nerve cells—called circuits—in the brain that normally regulate responses to natural rewards in the environment, like food, sex, and social interactions. The areas of brain involved...